ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,566.46
1.12%
US Tech 100
19,255.20
1.29%
Dow Jones
40,415.44
0.32%
Brent Oil
81.525
0.01%
Bitcoin
67,645.38
0.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Angion Biomedica Corporation (ANGN)

  7. Angion Biomedica Corporation (ANGN) News

ANGN

Angion Biomedica (ANGN)

Angion Biomedica Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANGN
DateTimeSourceHeadlineSymbolCompany
07/02/20244:39PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
07/02/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
06/28/20249:08PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ANGNAngion Biomedica Corporation
06/27/20244:42PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ANGNAngion Biomedica Corporation
06/27/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
04/29/20247:00AMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
04/05/20244:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
03/29/20243:28PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANGNAngion Biomedica Corporation
03/29/20243:26PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ANGNAngion Biomedica Corporation
03/29/20241:58PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGNAngion Biomedica Corporation
03/29/20248:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
03/20/20244:37PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
03/20/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
03/18/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
02/05/20246:01AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
02/05/20246:01AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
02/05/20246:01AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
02/05/20246:01AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
02/02/20248:51AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
01/17/20248:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
01/16/20247:59AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
01/09/20248:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
01/05/20244:05PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ANGNAngion Biomedica Corporation
12/29/20235:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
12/29/20235:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
12/26/20234:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGNAngion Biomedica Corporation
12/26/20234:25PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANGNAngion Biomedica Corporation
12/22/20239:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
11/13/20238:45AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGNAngion Biomedica Corporation
11/09/20234:41PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGNAngion Biomedica Corporation
 Showing the most relevant articles for your search:NASDAQ:ANGN

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
IDVV
International Endeavors (PK)
NYSE
AMC
AMC Entertainment
USOTC
MGON
Megola (PK)
USOTC
GRLT
Grillit (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
CNNA
Cann American (CE)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
HIRU
Hiru (PK)
USOTC
NBRI
North Bay Resources (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
CRTG
Coretec (QB)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved